Clinical trial

Application of S26E for Diabetic Foot Ulcer Healing

NCT04186377

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Standard-of-care for neuropathic/neuroischemic diabetic foot ulcers Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention S26E Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Application of S26E for Diabetic Foot Ulcer Healing

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2020-05-15

PhasePHASE2

Conditions

Diabetic Footunresolved

Neuropathic Foot Ulcerunresolved

Chronic Diabetic Ulcer of Left Foot (Diagnosis)unresolved

Chronic Diabetic Foot Ulcer of Right Footunresolved

Interventions

Standard-of-care for neuropathic/neuroischemic diabetic foot ulcersOTHER

S26EDRUG

Sponsors & collaborators

National and Kapodistrian University of Athenslead sponsor

Mapped research locations

AthensGreece1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04186377 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.